2017, Insurance and Pharmaceutical Companies

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Insurance Coverage

From data to impact: How real-world evidence will transform healthcare

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Documentation Labelling

Planning, not panic, as BIO weighs in on US vaccination woes

pharmaphorum

JUNE 19, 2025

Skip to main content Thursday 19 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Vaccines Pharmaceutical Companies Pharmaceutical Companies Insurance

J&J bids to extend prostate cancer uses for Akeega

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Insurance Coverage Insurance

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Packaging Insurance

Can I take Ozempic if I’m not diabetic?

The Checkup by Singlecare

AUGUST 14, 2024

Although GLP-1 drugs have been around since 2005, Ozempic was only made available in 2017. When a drug is in the pipeline of a clinical trial, the FDA requires the pharmaceutical company to be very specific in their hypothesis and tested patient population,” she explains. Insurance coverage varies by policy.

Labelling

Labelling FDA Insurance Insurance Coverage

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Packaging Insurance

What to know about generic Viagra

The Checkup by Singlecare

SEPTEMBER 7, 2023

The generic medication, sildenafil, became accessible in the United States in 2017. However, as the patent on Viagra expired, other pharmaceutical companies gained the opportunity to produce generic versions of the drug. Teva Pharmaceuticals entered the market with the first sildenafil generic in December 2017.

Dosage

Dosage Payment Processing Insurance Pharmaceutical Companies

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

JANUARY 10, 2023

In a manual for hemophilia treatment centers, the agency states it is concerned that providers would have no reason to participate in 340B if insurers take the benefit of 340B savings from them. HRSA published the proposed 340B "mega-guidance" the following year but ultimately withdrew it in 2017.

Hospitals

Hospitals Omnicell Insurance Documentation

Former Sanofi head Viehbacher to become Biogen CEO

pharmaphorum

NOVEMBER 11, 2022

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. A veritable ‘industry veteran’, he spent 20 years at GSK before Sanofi, where he helped reshape the company’s drug portfolio.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Insurance FDA

PQA Welcomes 11 New Members

PQA

MARCH 28, 2024

Learn more: [link] AstraZeneca is a global, science-led, patient-focused pharmaceutical company who is dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. AstraZeneca is focused on creating genuinely innovative medicines and improving access to them.

Specialty Pharmacies

Specialty Pharmacies Communication Pharmaceutical Companies Pharmaceutical Companies

PQA Welcomes 11 New Members

PQA

MARCH 27, 2024

Learn more: [link] AstraZeneca is a global, science-led, patient-focused pharmaceutical company who is dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. AstraZeneca is focused on creating genuinely innovative medicines and improving access to them.

Specialty Pharmacies

Specialty Pharmacies Communication Pharmaceutical Companies Pharmaceutical Companies

The Best Probiotics for Hashimoto’s

The Thyroid Pharmacist

OCTOBER 28, 2022

Please note, this is a very expensive probiotic, but you may be able to get it covered by your insurance if you have the right diagnosis. Allegedly, the inventor left the company, along with his proprietary recipe, and the product that the VSL #3 manufacturer has been making is different than the clinically tested product. 2017;8:1666.

Health and Personal Care Stores

Health and Personal Care Stores Immunization Grocery Stores Compounding

Cyltezo vs. Humira: Differences, similarities & side effects

The Checkup by Singlecare

JUNE 7, 2024

Humira is a brand-name medication made by the pharmaceutical company AbbVie, Inc. Cyltezo is an interchangeable biosimilar (similar to a generic, but for biologic drugs like Humira) made by Boehringer Ingelheim Pharmaceuticals, Inc. Contact your health insurance provider for the most recent pricing estimates.

Vaccines

Vaccines Insurance FDA Insurance Coverage

Pharmacy Technician Pulse

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

From data to impact: How real-world evidence will transform healthcare

Trending Sources

Planning, not panic, as BIO weighs in on US vaccination woes

J&J bids to extend prostate cancer uses for Akeega

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Can I take Ozempic if I’m not diabetic?

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

What to know about generic Viagra

The 20 Key Moments in the 340B Program's 30-Year History

Former Sanofi head Viehbacher to become Biogen CEO

PQA Welcomes 11 New Members

PQA Welcomes 11 New Members

The Best Probiotics for Hashimoto’s

Cyltezo vs. Humira: Differences, similarities & side effects

Stay Connected